Meiji Holdings Co. Ltd. Releases Transcript for FYE March 2026 Q3 Earnings Results Presentation
Meiji Holdings Co., Ltd. published the transcript of its FYE March 2026 Q3 earnings release presentation held on February 12, 2026, covering financial results for Q1 to Q3 (April 1, 2025 to December 31, 2025). The session was attended by Jun Hishinuma, CFO, Member of the Board and Managing Executive Officer. Management reported consolidated net sales of JPY882.3 billion, up 0.8% year on year, and operating profit of JPY70.0 billion, up 5.4%, noting performance was ahead of the company’s full-year plan. “Compared to the full-year plan, both net sales and operating profit were favorable,” Hishinuma said. Profit attributable to owners of the parent fell 11.0% to JPY38.8 billion due mainly to an impairment loss tied to production system optimization and lower gains on investment securities, though the CFO added, “We view these results as solid relative to our full-year plan.” In the Food segment, sales rose 1.3% to JPY711.1 billion and operating profit increased 8.4% to JPY53.6 billion, as price increases more than offset higher raw material costs, including cocoa and domestic raw milk. The company highlighted strong domestic dairy performance, including Meiji Probio Yogurt R-1 and functional yogurt launches, and steady progress on profitability improvement in China. Chocolate sales were strong in Japan and overseas, supported by price effects and growth of Hello Panda in the U.S., while the Nutrition business faced weaker infant formula volumes and tougher competition in powdered sports protein. Food solutions benefited from pricing and stronger B2B proposals in Japan, while China ice cream remained pressured by competition. In Pharmaceuticals, sales declined 1.1% to JPY172.2 billion but operating profit edged up 1.1% to JPY20.5 billion, with growth in REZUROCK and blood plasma products offsetting sluggish antibacterial drugs and a weak COVID-19 vaccine environment. Looking ahead, Meiji maintained its full-year outlook, with Hishinuma saying, “There is no change, as the cumulative Q3 results progressed well against the full-year plan revised in November.” The full transcript can be accessed through the link below.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Meiji Holdings Co. Ltd. published the original content used to generate this news brief on February 26, 2026, and is solely responsible for the information contained therein.
